Iloprost ameliorates post-ischemic lung reperfusion injury and maintains an appropriate pulmonary ET-1 balance

Journal of Heart and Lung Transplantation

Volumn 22, Issue 7, 2003, Pages 794-801

  Kawashima, Masahiro ^a,b   Nakamura, Takayuki ^b   Schneider, Sven ^a   Vollmar, Brigitte ^a   Lausberg, Henning F ^a   Bauer, Michael ^a   Menger, Michael D ^a   Schäfers, Hans Joachim ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN 1; ILOPROST; OXYGEN; PROSTACYCLIN DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL OXYGEN TENSION; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; DRUG EFFECT; ISCHEMIA; LUNG ARTERY PRESSURE; LUNG DISEASE; LUNG EDEMA; LUNG PERFUSION; LUNG VASCULAR RESISTANCE; MALE; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; PULMONARY VEIN; RANDOMIZATION; RAT; REPERFUSION INJURY; STATISTICAL SIGNIFICANCE; TEMPERATURE;

EID: 0038503399     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-2498(02)00646-0     Document Type: Article

References (31)

1. Allison R.C., Kyle J., Adkins W.K., Prasad V.R., McCord J.M., Taylor A.E. Effect of ischemia reperfusion or hypoxia reoxygenation on lung vascular permeability and resistance. J Appl Physiol. 69:1990;597-603.
2. Hosenpud J.D., Bennett L.E., Keck B.M., Boucek M.M., Novick R.J. The Registry of the International Society for Heart and Lung Transplantation seventeenth official report - 2000 . J Heart Lung Transplant. 19:2000;909-931.
3. Fiser S.M., Tribble C.G., Long S.M., et al. Ischemia-reperfusion injury after lung transplantation increases risk of late bronchiolitis obliterans syndrome. Ann Thorac Surg. 73:2002;1041-1047.
4. Puskas J.D., Cardoso P.F., Mayer E., Shi S., Slutsky A.S., Patterson G.A. Equivalent eighteen-hour lung preservation with low-potassium dextran or Euro-Collins solution after prostaglandin E1 infusion. J Thorac Cardiovasc Surg. 104:1992;83-89.
5. Hooper T.L., Fetherston G.J., Flecknell P.A., Dark J.H., McGregor C.G. The use of a prostacyclin analog, iloprost, as an adjunct to pulmonary preservation with Euro-Collins solution. Transplantation. 49:1990;495-499.
6. Hooper T.L., Thomson D.S., Jones M.T., et al. Amelioration of lung ischemic injury with prostacyclin. Transplantation. 49:1990;1031-1035.
7. Yamashita C., Oobo H., Tsuji F., et al. Effect of prostaglandin I2 and superoxide dismutase on reperfusion injury of warm ischemic lung. Ann Thorac Surg. 54:1992;921-924.
8. Okada Y., Marchevsky A.M., Kass R.M., Matloff J.M., Jordan S.C. A stable prostacyclin analog, beraprost sodium, attenuates platelet accumulation and preservation-reperfusion injury of isografts in a rat model of lung transplantation. Transplantation. 66:1998;1132-1136.
9. Riva C.M., Morganroth M.L., Ljungman A.G., et al. Iloprost inhibits neutrophil-induced lung injury and neutrophil adherence to endothelial monolayers. Am J Respir Cell Mol Biol. 3:1990;301-309.
10. Takeuchi K., Suzuki S., Kako N., et al. A prostacyclin analogue reduces free radical generation in heart-lung transplantation. Ann Thorac Surg. 54:1992;327-332.
11. Araki H., Lefer A.M. Cytoprotective actions of prostacyclin during hypoxia in the isolated perfused cat liver. Am J Physiol. 238:1980;H176-181.
12. Xiao C.Y., Hara A., Yuhki K., et al. Roles of prostaglandin I(2) and thromboxane A(2) in cardiac ischemia-reperfusion injury a study using mice lacking their respective receptors . Circulation. 104:2001;2210-2215.
13. Coleman R.A., Smith W.L., Narumiya S. International Union of Pharmacology classification of prostanoid receptors properties, distribution, and structure of the receptors and their subtypes . Pharmacol Rev. 46:1994;205-229.
14. Suttorp N., Weber U., Welsch T., Schudt C. Role of phosphodiesterases in the regulation of endothelial permeability in vitro. J Clin Invest. 91:1993;1421-1428.
15. Naka Y., Roy D.K., Liao H., et al. cAMP-mediated vascular protection in an orthotopic rat lung transplant model Insights into the mechanism of action of prostaglandin E1 to improve lung preservation . Circ Res. 79:1996;773-783.
16. Jiang X.W., Kambara K., Gotoh N., Nishigaki K., Fujiwara H. Effects of low-dose beraprost sodium, a stable prostaglandin I2 analogue, on reperfusion injury to rabbit lungs. Am J Respir Crit Care Med. 158:1998;1669-1675.
17. Urabe N., Fujisawa T., Saitoh Y., et al. The capacity of dog lung to release prostaglandin I2 as a biochemical parameter for evaluating lung damage during preservation. Transplantation. 57:1994;194-198.
18. Novick R.J., Reid K.R., Denning L., Duplan J., Menkis A.H., McKenzie F.N. Prolonged preservation of canine lung allografts the role of prostaglandins . Ann Thorac Surg. 51:1991;853-859.
19. Luscher T.F., Barton M. Endothelins and endothelin receptor antagonists therapeutic considerations for a novel class of cardiovascular drugs . Circulation. 102:2000;2434-2440.
20. Levin E.R. Endothelins. N Engl J Med. 333:1995;356-363.
21. Langleben D., Barst R.J., Badesch D., et al. Continuous infusion of epoprostenol improves the net balance between pulmonary endothelin-1 clearance and release in primary pulmonary hypertension. Circulation. 99:1999;3266-3271.
22. Okada M., Yamashita C., Okada K. Contribution of endothelin-1 to warm ischemia/reperfusion injury of the rat lung. Am J Respir Crit Care Med. 152:1995;2105-2110.
23. Rubens C., Ewert R., Halank M., et al. Big endothelin-1 and endothelin-1 plasma levels are correlated with the severity of primary pulmonary hypertension. Chest. 120:2001;1562-1569.
24. Hemsen A., Ahlborg G., Ottosson-Seeberger A., Lundberg J.M. Metabolism of Big endothelin-1 (1-38) and (22-38) in the human circulation in relation to production of endothelin-1 (1-21). Regul Pept. 55:1995;287-297.
25. Prins B.A., Hu R.M., Nazario B., et al. Prostaglandin E2 and prostacyclin inhibit the production and secretion of endothelin from cultured endothelial cells. J Biol Chem. 269:1994;11938-11944.
26. Stewart D.J., Cernacek P., Mohamed F., Blais D., Cianflone K., Monge J.C. Role of cyclic nucleotides in the regulation of endothelin-1 production by human endothelial cells. Am J Physiol. 266:1994;H944-951.
27. Hausen B., Muller P., Bahra M., Ramsamooj R., Hewitt C.W. Donor pretreatment with intravenous prostacyclin versus inhaled nitric oxide in experimental lung transplantation. Transplantation. 62:1996;1714-1719.
28. Matsuzaki Y., Waddell T.K., Puskas J.D., et al. Amelioration of post-ischemic lung reperfusion injury by prostaglandin E1. Am Rev Respir Dis. 148:1993;882-889.
29. Gurtner G.H., Burke-Wolin T. Interactions of oxidant stress and vascular reactivity. Am J Physiol. 260:1991;L207-211.
30. Bhabra M.S., Hopkinson D.N., Shaw T.E., Hooper T.L. Critical importance of the first 10 minutes of lung graft reperfusion after hypothermic storage. Ann Thorac Surg. 61:1996;1631-1635.
31. Renaud F., Succo E., Alessi M.C., Legre R., Juhan-Vague I. Iloprost and salvage of a free flap. Br J Plast Surg. 49:1996;245-248.